Skip to content

Structure Therapeutics Inc Sustainability Reports

A clinical-stage biopharmaceutical company developing oral small molecule therapeutics for chronic diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

FIGI: BBG01CBVHMQ6

2 reports from 2023 to 2024